Suppr超能文献

慢性胺碘酮治疗期间的甲状腺肿和甲状腺功能障碍。

Goitre and thyroid dysfunction during chronic amiodarone treatment.

作者信息

Eason R J, Croxson M S, Lim T M, Evans M C, Cooper G J

出版信息

N Z Med J. 1984 Apr 11;97(753):216-9.

PMID:6585712
Abstract

We measured thyroid function in a cross-sectional survey of 37 unselected patients receiving chronic amiodarone treatment. Palpable goitre was presented in 17 patients and was a new finding in ten. Despite frequent elevations of serum free T4 (67%) or free T4 index (43%), all 37 patients were clinically euthyroid with a normal or decreased serum free T3 or free T3 index. Mean urine iodide/creatinine excretion was increased 13-fold. Three patterns of thyroid function were seen; in 21 patients with normal TRH responses, the mean basal serum TSH was significantly elevated. Five patients had biochemical hypothyroidism which did not require treatment. Eleven patients had evidence of thyroid autonomy and the three patients with absent TRH responses each gave a past history of goitre or thyrotoxicosis; a trial of carbimazole treatment in these three was without clinical benefit. The observed spectrum of subclinical goitre and thyroid dysfunction may result from an unpredictable thyroid response to excessive free iodide combined with a weak goitrogenic effect of amiodarone mediated by increased TSH secretion.

摘要

我们对37例接受慢性胺碘酮治疗的未经过挑选的患者进行了横断面调查,测定其甲状腺功能。17例患者可触及甲状腺肿大,其中10例为新发现。尽管血清游离T4(67%)或游离T4指数(43%)频繁升高,但所有37例患者临床甲状腺功能正常,血清游离T3或游离T3指数正常或降低。尿碘/肌酐排泄均值增加了13倍。观察到三种甲状腺功能模式;21例促甲状腺激素释放激素(TRH)反应正常的患者,基础血清促甲状腺激素(TSH)均值显著升高。5例患者有生化性甲状腺功能减退,但无需治疗。11例患者有甲状腺自主性证据,3例无TRH反应的患者均有甲状腺肿大或甲状腺毒症病史;对这3例患者进行的卡比马唑治疗试验无临床益处。观察到的亚临床甲状腺肿大和甲状腺功能障碍谱可能是由于甲状腺对过量游离碘的不可预测反应,以及胺碘酮通过增加TSH分泌介导的微弱致甲状腺肿作用所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验